# Eli Lilly announces $850 million investment in U.S. operations in 2017

Eli Lilly announced plans to invest $850 million in its U.S. operations in 2017, including an $85 million expansion of Trulicity device assembly operations and a $140 million insulin cartridge production facility in Indianapolis.

- Type: Investment
- Announced: 2017-03-31
- Where: Indianapolis, Indiana, United States
- Value: $850.0M
- Status: announced
- Products: Trulicity device assembly, insulin cartridges
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Eli Lilly and Company](https://endata.com/companies/16522.md)

## Sources

- [drugdiscoverytrends.com](https://www.drugdiscoverytrends.com/eli-lilly-announces-850m-investment-in-u-s-capital-projects-in-2017/), 2017-03-31: "Eli Lilly and Company announced plans to invest $850 million in its U.S. operations in 2017."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.